Le Lézard
Classified in: Health, Science and technology
Subject: SVY

PharmaForce International: Key US Immunology-Focused Organizations Expanded into the Respiratory Space in 2022

READING, Pa., March 28, 2023 /PRNewswire/ -- PharmaForce International (PFI) recently published a report in December that benchmarked the leading Immunology sales and marketing organizations in the United States. This report focused on the key companies with products competing across the Dermatology, Gastroenterology, and Rheumatology markets throughout 2022. In addition to those three therapeutic areas of focus, the Respiratory space has also become a key area of interest. Many profiled companies have started to promote Respiratory products under their Immunology divisions.

Since the last Immunology report, which was published in December 2021, several Respiratory products were added to the 2022 scope due to all of these products aligning to an Immunology division. Immunology-focused companies have started deploying dedicated Respiratory sales lines to support Respiratory franchises. The report finds that the Respiratory products have not only solidified product priority within sales representatives' product weightings, but have also given more treatment options to both healthcare professionals and patients with asthma.

Allison Keylor, Director of the United States Business Unit at PFI, states, "When I think about the current Immunology space, the first aspect that comes to mind is the pioneering of new therapies that result in more options for patients and caregivers. The influx of respiratory products coupled with generic/biosimilar pressures has made for a dynamic selling environment."

"The respiratory focused products have definitely given way for the Immunology space to expand both with products and field deployed personnel. The addition of respiratory biologics has also ushered in more coordinators that focus solely on buy and bill products," says Keylor.

In addition to the United States, the Immunology benchmarking study has also been conducted in the EU5 (France, Germany, Italy, Spain, and the UK). The EU5 Immunology report was published in November 2022. The 2023 updates for both the US and EU5 Immunology reports are anticipated to be published in Q4 2023.

For more information on the reports mentioned above, please contact Joyce Wedemeyer at Joyce.Wedemeyer@pharmaforceintl.com or by phone at 610-370-2906.

PharmaForce International (PFI) is a competitive intelligence firm with over two decades of experience in the pharmaceutical and biotech industries. PFI has become the market leader in commercial operations benchmarking and competitive intelligence.

SOURCE PharmaForce International

These press releases may also interest you

at 11:30
Professional Parking Technologies LLC (ProParking.com) today announced a partnership with UbiPark, becoming UbiPark's sales, installation, and servicing representative across the United States. Based in Melbourne, Australia, UbiPark has...

at 11:30
The "5G - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering. At the end of 2022, 1.7 billion people had a 5G mobile subscription, accounting for 18% of total mobile subscriptions worldwide. This figure is expected to...

at 11:30
Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance....

at 11:30
SchoolMint, the leading edtech provider of Strategic Enrollment Management solutions for schools and districts in K-12, announced the opening of its new headquarters in Lafayette, LA. The grand opening event featured a ribbon-cutting ceremony and a...

at 11:26
Moxo, the industry's leading external project workflow solution, has been named a leader in G2's Spring 2023 Grid® for Customer Communications Management Software and Grid® for Client Portal Software....

at 11:25
AlphaStreet, a leading fintech firm, announced the launch of AlphaStreet Intelligence. This pioneering, AI-driven market intelligence platform aims to transform how market intelligence is generated and utilized by companies, investors, analysts, and...

News published on and distributed by: